Light Mode
$9.13 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.13, $0.34 below the day’s high of $9.48
-10.28 (-52.96%) / 6M
Momentum, market sentiment, and recent alerts
SNDX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -46.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include Revuforj and Niktimvo. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.